Selective sentinel lymph node mapping and dissection for malignant melanoma.
Leong
Stanley P L
SP
Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco Medical Center at Mount Zion, UCSF Comprehensive Cancer Center, San Francisco, California, USA.
D000328:Adult; D000368:Aged; D004396:Coloring Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D015902:Gamma Cameras; D006801:Humans; D007430:Intraoperative Care; D008197:Lymph Node Excision / Q000379:methods*; D008207:Lymphatic Metastasis / Q000175:diagnosis* / Q000000981:diagnostic imaging; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000556:secondary* / Q000601:surgery; D011300:Preoperative Care; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D021701:Sentinel Lymph Node Biopsy / Q000295:instrumentation / Q000379:methods*; D012878:Skin Neoplasms / Q000473:pathology* / Q000601:surgery; D016896:Treatment Outcome
D004396:Coloring Agents; D019275:Radiopharmaceuticals